Development and Characterization of a Porcine Mitral Valve Scaffold for Tissue Engineering

Publikation: Beitrag in FachzeitschriftArtikelForschungPeer-Review

Autoren

  • M. Granados
  • L. Morticelli
  • S. Andriopoulou
  • P. Kalozoumis
  • M. Pflaum
  • P. Iablonskii
  • Birgit Glasmacher
  • M. Harder
  • Jan Hegermann
  • C. Wrede
  • I. Tudorache
  • S. Cebotari
  • A. Hilfiker
  • A. Haverich
  • Sotirios Korossis

Organisationseinheiten

Externe Organisationen

  • Medizinische Hochschule Hannover (MHH)
  • Leibniz Forschungslaboratorien für Biotechnologie und künstliche Organe (LEBAO)
  • Corlife OHG
Forschungs-netzwerk anzeigen

Details

OriginalspracheEnglisch
Seiten (von - bis)374-390
Seitenumfang17
FachzeitschriftJournal of Cardiovascular Translational Research
Jahrgang10
Ausgabenummer4
Frühes Online-Datum1 Mai 2017
PublikationsstatusVeröffentlicht - Aug. 2017

Abstract

Decellularized scaffolds represent a promising alternative for mitral valve (MV) replacement. This work developed and characterized a protocol for the decellularization of whole MVs. Porcine MVs were decellularized with 0.5% (w/v) SDS and 0.5% (w/v) SD and sterilized with 0.1% (v/v) PAA. Decellularized samples were seeded with human foreskin fibroblasts and human adipose-derived stem cells to investigate cellular repopulation and infiltration, and with human colony-forming endothelial cells to investigate collagen IV formation. Histology revealed an acellular scaffold with a generally conserved histoarchitecture, but collagen IV loss. Following decellularization, no significant changes were observed in the hydroxyproline content, but there was a significant reduction in the glycosaminoglycan content. SEM/TEM analysis confirmed cellular removal and loss of some extracellular matrix components. Collagen and elastin were generally preserved. The endothelial cells produced newly formed collagen IV on the non-cytotoxic scaffold. The protocol produced acellular scaffolds with generally preserved histoarchitecture, biochemistry, and biomechanics.

ASJC Scopus Sachgebiete

Ziele für nachhaltige Entwicklung

Zitieren

Development and Characterization of a Porcine Mitral Valve Scaffold for Tissue Engineering. / Granados, M.; Morticelli, L.; Andriopoulou, S. et al.
in: Journal of Cardiovascular Translational Research, Jahrgang 10, Nr. 4, 08.2017, S. 374-390.

Publikation: Beitrag in FachzeitschriftArtikelForschungPeer-Review

Granados, M, Morticelli, L, Andriopoulou, S, Kalozoumis, P, Pflaum, M, Iablonskii, P, Glasmacher, B, Harder, M, Hegermann, J, Wrede, C, Tudorache, I, Cebotari, S, Hilfiker, A, Haverich, A & Korossis, S 2017, 'Development and Characterization of a Porcine Mitral Valve Scaffold for Tissue Engineering', Journal of Cardiovascular Translational Research, Jg. 10, Nr. 4, S. 374-390. https://doi.org/10.1007/s12265-017-9747-z
Granados, M., Morticelli, L., Andriopoulou, S., Kalozoumis, P., Pflaum, M., Iablonskii, P., Glasmacher, B., Harder, M., Hegermann, J., Wrede, C., Tudorache, I., Cebotari, S., Hilfiker, A., Haverich, A., & Korossis, S. (2017). Development and Characterization of a Porcine Mitral Valve Scaffold for Tissue Engineering. Journal of Cardiovascular Translational Research, 10(4), 374-390. https://doi.org/10.1007/s12265-017-9747-z
Granados M, Morticelli L, Andriopoulou S, Kalozoumis P, Pflaum M, Iablonskii P et al. Development and Characterization of a Porcine Mitral Valve Scaffold for Tissue Engineering. Journal of Cardiovascular Translational Research. 2017 Aug;10(4):374-390. Epub 2017 Mai 1. doi: 10.1007/s12265-017-9747-z
Granados, M. ; Morticelli, L. ; Andriopoulou, S. et al. / Development and Characterization of a Porcine Mitral Valve Scaffold for Tissue Engineering. in: Journal of Cardiovascular Translational Research. 2017 ; Jahrgang 10, Nr. 4. S. 374-390.
Download
@article{a261d334a3f24374946129df6fde86af,
title = "Development and Characterization of a Porcine Mitral Valve Scaffold for Tissue Engineering",
abstract = "Decellularized scaffolds represent a promising alternative for mitral valve (MV) replacement. This work developed and characterized a protocol for the decellularization of whole MVs. Porcine MVs were decellularized with 0.5% (w/v) SDS and 0.5% (w/v) SD and sterilized with 0.1% (v/v) PAA. Decellularized samples were seeded with human foreskin fibroblasts and human adipose-derived stem cells to investigate cellular repopulation and infiltration, and with human colony-forming endothelial cells to investigate collagen IV formation. Histology revealed an acellular scaffold with a generally conserved histoarchitecture, but collagen IV loss. Following decellularization, no significant changes were observed in the hydroxyproline content, but there was a significant reduction in the glycosaminoglycan content. SEM/TEM analysis confirmed cellular removal and loss of some extracellular matrix components. Collagen and elastin were generally preserved. The endothelial cells produced newly formed collagen IV on the non-cytotoxic scaffold. The protocol produced acellular scaffolds with generally preserved histoarchitecture, biochemistry, and biomechanics.",
keywords = "Biochemistry, Biocompatibility, Biomechanics, Collagen IV, Cytotoxicity, Decellularization, Heart valve replacement, Histology, Human adipose-derived stem cells, Human colony-forming endothelial cells, Human foreskin fibroblasts, Immunohistochemistry, Mitral valve, Scaffold, Scaffold seeding, Scanning electron microscopy, Tissue engineering, Transmission electron microscopy, Xenoepitope, α-Gal",
author = "M. Granados and L. Morticelli and S. Andriopoulou and P. Kalozoumis and M. Pflaum and P. Iablonskii and Birgit Glasmacher and M. Harder and Jan Hegermann and C. Wrede and I. Tudorache and S. Cebotari and A. Hilfiker and A. Haverich and Sotirios Korossis",
note = "Funding Information: Acknowledgements The authors would like to acknowledge the contribution of Karin Burgwitz and Annemarie Beck at the Lower Saxony Centre for Biomedical Engineering Implant Research and Development for their technical support on histological and immunohistochemical analysis. This research was supported by the People Programme (Marie Curie Actions) of the EU 7th Framework Programme FP7/2007–2013/ under the REA grant agreement number 317512, and the German Research Foundation through the Cluster of Excellence REBIRTH (From Regenerative Biology to Reconstructive Therapy; EXC 62). Funding Information: The authors would like to acknowledge the contribution of Karin Burgwitz and Annemarie Beck at the Lower Saxony Centre for Biomedical Engineering Implant Research and Development for their technical support on histological and immunohistochemical analysis. This research was supported by the People Programme (Marie Curie Actions) of the EU 7th Framework Programme FP7/2007?2013/ under the REA grant agreement number 317512, and the German Research Foundation through the Cluster of Excellence REBIRTH (From Regenerative Biology to Reconstructive Therapy; EXC 62). Publisher Copyright: {\textcopyright} 2017, Springer Science+Business Media New York. Copyright: Copyright 2018 Elsevier B.V., All rights reserved.",
year = "2017",
month = aug,
doi = "10.1007/s12265-017-9747-z",
language = "English",
volume = "10",
pages = "374--390",
journal = "Journal of Cardiovascular Translational Research",
issn = "1937-5387",
publisher = "Springer New York",
number = "4",

}

Download

TY - JOUR

T1 - Development and Characterization of a Porcine Mitral Valve Scaffold for Tissue Engineering

AU - Granados, M.

AU - Morticelli, L.

AU - Andriopoulou, S.

AU - Kalozoumis, P.

AU - Pflaum, M.

AU - Iablonskii, P.

AU - Glasmacher, Birgit

AU - Harder, M.

AU - Hegermann, Jan

AU - Wrede, C.

AU - Tudorache, I.

AU - Cebotari, S.

AU - Hilfiker, A.

AU - Haverich, A.

AU - Korossis, Sotirios

N1 - Funding Information: Acknowledgements The authors would like to acknowledge the contribution of Karin Burgwitz and Annemarie Beck at the Lower Saxony Centre for Biomedical Engineering Implant Research and Development for their technical support on histological and immunohistochemical analysis. This research was supported by the People Programme (Marie Curie Actions) of the EU 7th Framework Programme FP7/2007–2013/ under the REA grant agreement number 317512, and the German Research Foundation through the Cluster of Excellence REBIRTH (From Regenerative Biology to Reconstructive Therapy; EXC 62). Funding Information: The authors would like to acknowledge the contribution of Karin Burgwitz and Annemarie Beck at the Lower Saxony Centre for Biomedical Engineering Implant Research and Development for their technical support on histological and immunohistochemical analysis. This research was supported by the People Programme (Marie Curie Actions) of the EU 7th Framework Programme FP7/2007?2013/ under the REA grant agreement number 317512, and the German Research Foundation through the Cluster of Excellence REBIRTH (From Regenerative Biology to Reconstructive Therapy; EXC 62). Publisher Copyright: © 2017, Springer Science+Business Media New York. Copyright: Copyright 2018 Elsevier B.V., All rights reserved.

PY - 2017/8

Y1 - 2017/8

N2 - Decellularized scaffolds represent a promising alternative for mitral valve (MV) replacement. This work developed and characterized a protocol for the decellularization of whole MVs. Porcine MVs were decellularized with 0.5% (w/v) SDS and 0.5% (w/v) SD and sterilized with 0.1% (v/v) PAA. Decellularized samples were seeded with human foreskin fibroblasts and human adipose-derived stem cells to investigate cellular repopulation and infiltration, and with human colony-forming endothelial cells to investigate collagen IV formation. Histology revealed an acellular scaffold with a generally conserved histoarchitecture, but collagen IV loss. Following decellularization, no significant changes were observed in the hydroxyproline content, but there was a significant reduction in the glycosaminoglycan content. SEM/TEM analysis confirmed cellular removal and loss of some extracellular matrix components. Collagen and elastin were generally preserved. The endothelial cells produced newly formed collagen IV on the non-cytotoxic scaffold. The protocol produced acellular scaffolds with generally preserved histoarchitecture, biochemistry, and biomechanics.

AB - Decellularized scaffolds represent a promising alternative for mitral valve (MV) replacement. This work developed and characterized a protocol for the decellularization of whole MVs. Porcine MVs were decellularized with 0.5% (w/v) SDS and 0.5% (w/v) SD and sterilized with 0.1% (v/v) PAA. Decellularized samples were seeded with human foreskin fibroblasts and human adipose-derived stem cells to investigate cellular repopulation and infiltration, and with human colony-forming endothelial cells to investigate collagen IV formation. Histology revealed an acellular scaffold with a generally conserved histoarchitecture, but collagen IV loss. Following decellularization, no significant changes were observed in the hydroxyproline content, but there was a significant reduction in the glycosaminoglycan content. SEM/TEM analysis confirmed cellular removal and loss of some extracellular matrix components. Collagen and elastin were generally preserved. The endothelial cells produced newly formed collagen IV on the non-cytotoxic scaffold. The protocol produced acellular scaffolds with generally preserved histoarchitecture, biochemistry, and biomechanics.

KW - Biochemistry

KW - Biocompatibility

KW - Biomechanics

KW - Collagen IV

KW - Cytotoxicity

KW - Decellularization

KW - Heart valve replacement

KW - Histology

KW - Human adipose-derived stem cells

KW - Human colony-forming endothelial cells

KW - Human foreskin fibroblasts

KW - Immunohistochemistry

KW - Mitral valve

KW - Scaffold

KW - Scaffold seeding

KW - Scanning electron microscopy

KW - Tissue engineering

KW - Transmission electron microscopy

KW - Xenoepitope

KW - α-Gal

UR - http://www.scopus.com/inward/record.url?scp=85018361266&partnerID=8YFLogxK

U2 - 10.1007/s12265-017-9747-z

DO - 10.1007/s12265-017-9747-z

M3 - Article

C2 - 28462436

AN - SCOPUS:85018361266

VL - 10

SP - 374

EP - 390

JO - Journal of Cardiovascular Translational Research

JF - Journal of Cardiovascular Translational Research

SN - 1937-5387

IS - 4

ER -